JP2010523096A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010523096A5 JP2010523096A5 JP2010501503A JP2010501503A JP2010523096A5 JP 2010523096 A5 JP2010523096 A5 JP 2010523096A5 JP 2010501503 A JP2010501503 A JP 2010501503A JP 2010501503 A JP2010501503 A JP 2010501503A JP 2010523096 A5 JP2010523096 A5 JP 2010523096A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- functional derivative
- epcam
- epcam antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07105628.7 | 2007-04-04 | ||
| EP07105628 | 2007-04-04 | ||
| PCT/EP2008/053913 WO2008122551A2 (en) | 2007-04-04 | 2008-04-02 | Anti-epcam antibody and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010523096A JP2010523096A (ja) | 2010-07-15 |
| JP2010523096A5 true JP2010523096A5 (enExample) | 2011-08-11 |
| JP5631733B2 JP5631733B2 (ja) | 2014-11-26 |
Family
ID=38458122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010501503A Expired - Fee Related JP5631733B2 (ja) | 2007-04-04 | 2008-04-02 | 抗ＥｐＣＡＭ抗体およびその使用 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8318911B2 (enExample) |
| EP (1) | EP2142570B1 (enExample) |
| JP (1) | JP5631733B2 (enExample) |
| KR (1) | KR101683884B1 (enExample) |
| CN (1) | CN101970497B (enExample) |
| AT (1) | ATE512988T1 (enExample) |
| AU (1) | AU2008235566B2 (enExample) |
| BR (1) | BRPI0810096A8 (enExample) |
| CA (1) | CA2682296C (enExample) |
| CY (1) | CY1111819T1 (enExample) |
| DK (1) | DK2142570T3 (enExample) |
| EA (1) | EA023679B1 (enExample) |
| ES (1) | ES2367675T3 (enExample) |
| HR (1) | HRP20110620T1 (enExample) |
| IL (1) | IL201196A0 (enExample) |
| MX (1) | MX2009010444A (enExample) |
| PL (1) | PL2142570T3 (enExample) |
| PT (1) | PT2142570E (enExample) |
| RS (1) | RS52040B (enExample) |
| SI (1) | SI2142570T1 (enExample) |
| WO (1) | WO2008122551A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2474822A1 (en) | 2003-01-24 | 2012-07-11 | University of Utah | Methods of predicting mortality risk by determining telomere length |
| CA2748265C (en) | 2008-12-22 | 2018-04-03 | University Of Utah Research Foundation | Monochrome multiplex quantitative pcr |
| GB0909904D0 (en) * | 2009-06-09 | 2009-07-22 | Affitech As | Product |
| CA2830349C (en) | 2011-03-17 | 2019-07-16 | The University Of Birmingham | Re-directed immunotherapy |
| EP2710042A2 (en) * | 2011-05-16 | 2014-03-26 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| WO2013003624A2 (en) | 2011-06-29 | 2013-01-03 | Academia Sinica | The capture, purification and release of biological substance using a surface coating |
| EP2819695B1 (en) * | 2012-03-02 | 2018-06-27 | Academia Sinica | ANTI-EPITHELIAL CELL ADHESION MOLECULE (EpCAM) ANTIBODIES AND METHODS OF USE THEREOF |
| US9494500B2 (en) | 2012-10-29 | 2016-11-15 | Academia Sinica | Collection and concentration system for biologic substance of interest and use thereof |
| EP2999800B1 (en) | 2013-05-22 | 2019-09-25 | Telomere Diagnostics Inc. | Measures of short telomere abundance |
| EP3126814B1 (en) | 2014-04-01 | 2019-06-12 | Academia Sinica | Methods and systems for cancer diagnosis and prognosis |
| US10112198B2 (en) | 2014-08-26 | 2018-10-30 | Academia Sinica | Collector architecture layout design |
| CA2971169A1 (en) | 2014-12-30 | 2016-07-07 | Telomere Diagnostics, Inc. | Multiplex quantitative pcr |
| WO2017023704A1 (en) * | 2015-07-31 | 2017-02-09 | Sutro Biopharma, Inc. | ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIES |
| US10107726B2 (en) | 2016-03-16 | 2018-10-23 | Cellmax, Ltd. | Collection of suspended cells using a transferable membrane |
| US11046782B2 (en) | 2016-03-30 | 2021-06-29 | Musc Foundation For Research Development | Methods for treatment and diagnosis of cancer by targeting glycoprotein A repetitions predominant (GARP) and for providing effective immunotherapy alone or in combination |
| KR20190038567A (ko) | 2016-07-26 | 2019-04-08 | 테사 테라퓨틱스 피티이. 엘티디. | 키메라 항원 수용체 |
| WO2020018964A1 (en) | 2018-07-20 | 2020-01-23 | Fred Hutchinson Cancer Research Center | Compositions and methods for controlled expression of antigen-specific receptors |
| EP3847196A4 (en) | 2018-09-07 | 2023-01-04 | ITabMed (HK) Limited | BISPECIFIC ANTIGEN BINDING PROTEINS AND USES THEREOF |
| AU2019402097A1 (en) | 2018-12-17 | 2021-06-10 | Revitope Limited | Twin immune cell engager |
| WO2020216210A1 (zh) * | 2019-04-22 | 2020-10-29 | 江苏恒瑞医药股份有限公司 | 抗EpCAM抗体及其应用 |
| AU2020292304B2 (en) * | 2019-06-11 | 2023-03-30 | Bioatla, Inc. | Conditionally active anti-EpCam antibodies, antibody fragments, their immunoconjugates and uses thereof |
| CN110950959B (zh) * | 2020-02-25 | 2020-07-03 | 和铂医药(上海)有限责任公司 | 靶向EpCAM的抗体及其制备和应用 |
| CN112094350B (zh) * | 2020-06-01 | 2024-01-05 | 普众发现医药科技(上海)有限公司 | 可应用于肿瘤细胞捕获的小鼠抗细胞表面糖蛋白cd326的单克隆抗体 |
| EP4190808A4 (en) * | 2020-08-19 | 2024-07-31 | Suzhou Immunofoco Biotechnology Co., Ltd. | Humanized antibody, chimeric antigen receptor, nucleic acid, vector, cell and use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4675187A (en) | 1983-05-16 | 1987-06-23 | Bristol-Myers Company | BBM-1675, a new antibiotic complex |
| US5525338A (en) | 1992-08-21 | 1996-06-11 | Immunomedics, Inc. | Detection and therapy of lesions with biotin/avidin conjugates |
| IT1245748B (it) | 1990-12-21 | 1994-10-14 | Mini Ricerca Scient Tecnolog | Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego |
| US5578287A (en) | 1992-06-09 | 1996-11-26 | Neorx Corporation | Three-step pretargeting methods using improved biotin-active agent |
| JP3427871B2 (ja) | 1996-06-24 | 2003-07-22 | 戸田工業株式会社 | コバルト被着型針状磁性酸化鉄粒子粉末 |
| ITRM20010079A1 (it) | 2001-02-16 | 2002-08-16 | Sigma Tau Ind Farmaceuti | Amminoderivati della biotina e loro coniugati con chelanti macrociclici. |
| US20050180979A1 (en) * | 2004-02-13 | 2005-08-18 | Micromet Ag | Anti-EpCAM immunoglobulins |
| US7435804B2 (en) * | 2004-10-19 | 2008-10-14 | Phage Biotechnology, Inc. | Method for obtaining single chain antibodies to human interferon α2b |
-
2008
- 2008-04-02 EP EP08759374A patent/EP2142570B1/en active Active
- 2008-04-02 AU AU2008235566A patent/AU2008235566B2/en not_active Ceased
- 2008-04-02 PT PT08759374T patent/PT2142570E/pt unknown
- 2008-04-02 CA CA2682296A patent/CA2682296C/en not_active Expired - Fee Related
- 2008-04-02 SI SI200830364T patent/SI2142570T1/sl unknown
- 2008-04-02 HR HR20110620T patent/HRP20110620T1/hr unknown
- 2008-04-02 ES ES08759374T patent/ES2367675T3/es active Active
- 2008-04-02 MX MX2009010444A patent/MX2009010444A/es active IP Right Grant
- 2008-04-02 KR KR1020097023099A patent/KR101683884B1/ko not_active Expired - Fee Related
- 2008-04-02 AT AT08759374T patent/ATE512988T1/de active
- 2008-04-02 DK DK08759374.5T patent/DK2142570T3/da active
- 2008-04-02 JP JP2010501503A patent/JP5631733B2/ja not_active Expired - Fee Related
- 2008-04-02 EA EA200970923A patent/EA023679B1/ru not_active IP Right Cessation
- 2008-04-02 CN CN200880015767.4A patent/CN101970497B/zh not_active Expired - Fee Related
- 2008-04-02 WO PCT/EP2008/053913 patent/WO2008122551A2/en not_active Ceased
- 2008-04-02 RS RS20110388A patent/RS52040B/sr unknown
- 2008-04-02 BR BRPI0810096A patent/BRPI0810096A8/pt not_active Application Discontinuation
- 2008-04-02 PL PL08759374T patent/PL2142570T3/pl unknown
- 2008-04-02 US US12/594,559 patent/US8318911B2/en not_active Expired - Fee Related
-
2009
- 2009-09-24 IL IL201196A patent/IL201196A0/en active IP Right Grant
-
2011
- 2011-09-06 CY CY20111100854T patent/CY1111819T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010523096A5 (enExample) | ||
| HRP20110620T1 (hr) | PROTUTIJELO PROTIV EpCAM I NJEGOVE UPOTREBE | |
| JP7209464B2 (ja) | ヒトインターロイキン－２に対する免疫刺激性モノクローナル抗体 | |
| RU2014149332A (ru) | Антитела против клаудина 18.2 для диагностики рака | |
| JP2019534034A5 (enExample) | ||
| JP2007526233A5 (enExample) | ||
| JP2009517057A5 (enExample) | ||
| JP2018504105A5 (enExample) | ||
| RU2016104057A (ru) | Новые белки, специфично связывающиеся с двумя мишенями -dll4 и vegf-, и их применение | |
| JP2017538439A5 (enExample) | ||
| RU2013125306A (ru) | Связывающие протеины, специфичные по отношению к инсулин-подобным факторам роста, и их использование | |
| JP2005538701A5 (enExample) | ||
| IL273196B1 (en) | Claudin 6 antibodies and methods of cancer treatment | |
| JP2006507013A5 (enExample) | ||
| JP2010510809A5 (enExample) | ||
| RU2015142815A (ru) | Лечение рака с использованием антител, связывающихся с поверхностным grp78 | |
| JP2019502405A5 (enExample) | ||
| JP2014524746A5 (enExample) | ||
| JP2021500916A5 (enExample) | ||
| JP2012531212A5 (enExample) | ||
| JP2009541204A5 (enExample) | ||
| JP2005528914A5 (enExample) | ||
| CN112513094A (zh) | 结合人her2的抗体、其制备方法和用途 | |
| RU2009137784A (ru) | Человеческое опухолеспецифическое моноклональное антитело | |
| JP2014515600A5 (enExample) |